|
CYP2C8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22013510406305E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.28389999929513E-08 |
| Normal-vs-Stage2 |
5.436700E-03 |
| Normal-vs-Stage3 |
1.40950000004914E-06 |
| Normal-vs-Stage4 |
1.157970E-04 |
| Stage1-vs-Stage2 |
5.805600E-01 |
| Stage1-vs-Stage3 |
9.724600E-01 |
| Stage1-vs-Stage4 |
2.517800E-01 |
| Stage2-vs-Stage3 |
5.811400E-01 |
| Stage2-vs-Stage4 |
7.655200E-01 |
| Stage3-vs-Stage4 |
2.672400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.77846667684889E-12 |
| Normal-vs-AfricanAmerican |
1.500740E-03 |
| Normal-vs-Asian |
2.550000E-01 |
| Caucasian-vs-AfricanAmerican |
7.705600E-01 |
| Caucasian-vs-Asian |
5.735800E-02 |
| AfricanAmerican-vs-Asian |
7.417800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81729997716928E-09 |
| Normal-vs-Female |
8.46230000517423E-08 |
| Male-vs-Female |
4.979800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.635020E-01 |
| Normal-vs-Age(41-60Yrs) |
8.3606455092422E-12 |
| Normal-vs-Age(61-80Yrs) |
3.01299999949656E-07 |
| Normal-vs-Age(81-100Yrs) |
1.844080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.620800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.852800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.366200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.006400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.495400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.744400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.858400E-03 |
| Normal-vs-Grade 2 |
2.66680000304831E-08 |
| Normal-vs-Grade 3 |
9.89560000608236E-09 |
| Normal-vs-Grade 4 |
5.523400E-03 |
| Grade 1-vs-Grade 2 |
5.251800E-01 |
| Grade 1-vs-Grade 3 |
1.661830E-01 |
| Grade 1-vs-Grade 4 |
1.342080E-02 |
| Grade 2-vs-Grade 3 |
1.380200E-01 |
| Grade 2-vs-Grade 4 |
5.642900E-03 |
| Grade 3-vs-Grade 4 |
7.836400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.73170000561385E-09 |
| Normal-vs-ccB subtype |
1.081240E-03 |
| ccA subtype-vs-ccB subtype |
9.392900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.9693026643306E-11 |
| Normal-vs-N1 |
1.816560E-01 |
| N0-vs-N1 |
3.511400E-01 |
|
|
